A detailed history of Larson Financial Group LLC transactions in Axogen, Inc. stock. As of the latest transaction made, Larson Financial Group LLC holds 221 shares of AXGN stock, worth $3,257. This represents 0.0% of its overall portfolio holdings.

Number of Shares
221
Previous 121 82.64%
Holding current value
$3,257
Previous $0 Infinity%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$7.52 - $14.69 $752 - $1,469
100 Added 82.64%
221 $3,000
Q1 2024

May 03, 2024

BUY
$6.63 - $10.69 $497 - $801
75 Added 163.04%
121 $0
Q4 2018

Feb 07, 2019

BUY
$17.09 - $38.25 $786 - $1,759
46 New
46 $1,000

Others Institutions Holding AXGN

About Axogen, Inc.


  • Ticker AXGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 42,283,700
  • Market Cap $623M
  • Description
  • AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...
More about AXGN
Track This Portfolio

Track Larson Financial Group LLC Portfolio

Follow Larson Financial Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Larson Financial Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Larson Financial Group LLC with notifications on news.